Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. - Wikidata - wikimedia - TriplyDB

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

http://www.wikidata.org/entity/Q39410014

about

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Regulation of Natural Killer Cell Function by STAT3 Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress Localization and upregulation of survivin in cancer health disparities: a clinical perspective Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma A novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapy A Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes Development-specific differences in the proteomics of Angiostrongylus cantonensis Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia.NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus.A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease Increase of IFN-γ and TNF-α production in CD107a + NK-92 cells co-cultured with cervical cancer cell lines pre-treated with the HO-1 inhibitor.Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction NK cells and T cells cooperate during the clinical course of colorectal cancer.Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression.Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differentia Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.Growth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells.Melanoma in immunosuppressed patients Lung tumor microenvironment induces specific gene expression signature in intratumoral NK cells.A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis.Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2.T and NK cells: two sides of tumor immunoevasion NK cells from malignant pleural effusions are potent antitumor effectors: A clue for adoptive immunotherapy?Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation.Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients.Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer.The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity.Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.

P2860

Q26746478-DCC314A3-C059-4345-B080-E61200CCA72F Q26752551-E061C533-DE87-49FB-8874-D5E8B193EF73 Q26771449-B5BA0032-5DFD-442B-AF15-AFD98DE528C2 Q26773135-4497E03F-044C-43F7-A933-E2ACE7637951 Q26781260-79BFCA8F-7B00-4125-8AD3-7B150E4D47B3 Q26799719-0C918CDA-3DAB-463F-A5EE-45D41437E678 Q26825075-C4C1DD50-8B8F-418F-BBC8-33A15DCAE42B Q26991949-DE9B0F3D-2DE8-44F5-9294-D0687D55FF63 Q27001052-46AA5C3F-E710-4661-9CA1-B14655C18F64 Q27308798-FEB7CDE4-5F84-4F7C-BD6B-33090F8E0B51 Q27312227-BEC33331-FF83-4B13-9C58-0EBD496C4DA8 Q27341786-DD4111DE-309E-423A-9B47-7FC500B76F9F Q28534634-97B3AB28-D630-47DF-A58A-F7EB2461EED6 Q33558780-E2A3BA4E-3B1E-4366-A661-01CAF8B98567 Q33682274-54F3BD49-59B2-460C-B9C4-44A06E83EE02 Q33785788-4EF19BDC-CDB5-4BB4-BBFF-6FA01A755AF1 Q34307792-27225905-0CDA-468A-A257-431F6A28F9D0 Q34308800-076FEA9B-A637-404E-B9F1-9D0B99E257EB Q34873308-16180D48-C3FC-4AE5-92BF-11EB925FFDF4 Q34933101-1D79E697-0ECA-4A19-A9F3-819B50C04F6E Q35034899-3BB343BE-2763-49E6-A2A4-B75C7B9EC51F Q35157437-4BB85B38-EFA9-4D6C-A3D0-38E51DB0A5DC Q35541252-75338DEA-767A-484C-A0A9-0AA38BEE43EE Q35674757-0F1449CA-6CA2-484D-8E3A-6BD4E9519913 Q35743162-A18C919F-EBC8-49D6-8663-0DA22F249918 Q35987354-EA269703-DD8B-4C16-9FA9-F6352895F761 Q36363166-F2ED9013-7471-48C4-B3F2-E87574D7EC94 Q36512842-2F8F6D3A-653B-4F6B-B073-B18ED592DECB Q36584068-6B0159DD-E1CD-41C2-8EE5-AB95FAAC3E40 Q36643655-920DA465-F8AB-44A1-B104-F76BB745BA98 Q36711029-BE603CB4-345A-4DCE-9A41-099943C1339A Q36753355-FD4408E1-632F-434F-BD37-C59E80A67D7C Q36845810-07501713-0DF1-475F-9145-87C9D8F1AF18 Q37120772-FB7DCDA0-9DC9-417B-B98E-CB0A6B041B8D Q37155165-E9A9944C-791C-45F5-A0D7-1E6AD8FD8C5D Q37257918-DC5F067C-2163-49C2-A6A8-EE838F41C573 Q37323082-AB8CE255-1FB2-4AB4-99C5-6C7F9A37CF74 Q37370451-769349C0-4C56-4382-8118-7C3E0E4F29B3 Q37413162-8B7956E1-904F-43C8-A351-28866F8D69A0 Q37615918-8B1A81E5-4002-4F7D-9448-BCA937DCC794

P2860

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

http://www.wikidata.org/entity/Q39410014

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Melanoma cells inhibit natural ...... eptors and cytolytic activity.

@en

Melanoma cells inhibit natural ...... eptors and cytolytic activity.

@nl

type

label

Melanoma cells inhibit natural ...... eptors and cytolytic activity.

@en

Melanoma cells inhibit natural ...... eptors and cytolytic activity.

@nl

prefLabel

Melanoma cells inhibit natural ...... eptors and cytolytic activity.

@en

Melanoma cells inhibit natural ...... eptors and cytolytic activity.

@nl

P1433

Q39410014-CA5737B6-7BDB-4B54-8F45-8037E298640D

P1476

Q39410014-BA180C6E-3B13-415F-ABDC-60CFF3C35A5C

P2093

Q39410014-051E2A6C-3611-4312-9916-BB7CA48A06DC

Q39410014-10391121-F94E-4159-A3ED-A70C288737B4

Q39410014-1D44551D-4F0D-4051-A541-94E4D08918AC

Q39410014-2A118C9C-E5B2-463D-B332-A7C634994E27

Q39410014-31D4666E-E1E6-4D5A-9F3B-6C4BE15BDF1E

Q39410014-45A1EBE8-2441-41C0-8CCE-6B20B7E3A76D

Q39410014-51AE5519-CB66-4AB7-98CC-22C0B7E408F9

Q39410014-5FAD7528-7AFD-4056-A7AC-B59AAA354A75

Q39410014-636E5D2F-EEAD-4BB2-B88A-0AC96893BEF5

Q39410014-940F2440-D995-4060-A487-2AF35CE1DEBF

P304

Q39410014-CA56DF65-A221-419A-877F-1D141C02D441

P31

Q39410014-8B6B4738-3F80-4146-BABB-951BC318BD19

P356

Q39410014-2DD04E29-639D-465A-B8FD-6ACB188CCD3D

P407

Q39410014-B6EF9F90-716B-42E7-8ACF-FB31A0D44F35

P433

Q39410014-C51F9BEA-66BD-4383-91E1-6F1C0CFE262E

P478

Q39410014-9729E12A-DE6A-4C13-96D5-C4158594DD2D

P577

Q39410014-6E371D12-D2D3-4BA7-A688-97DE67A2BB84

P698

Q39410014-3E8F3F8B-15AE-4A9B-9388-CDB02CCD551F

P356

0008-5472.CAN-11-2544

P1433

Cancer Research

P1476

Melanoma cells inhibit natural ...... eptors and cytolytic activity.

@en

P2093

Andrea Petretto

http://www.w3.org/2001/XMLSchema#string

Claudia Cantoni

http://www.w3.org/2001/XMLSchema#string

Claudia Manzini

http://www.w3.org/2001/XMLSchema#string

Gabriella Pietra

http://www.w3.org/2001/XMLSchema#string

Lorenzo Moretta

http://www.w3.org/2001/XMLSchema#string

Maria Cristina Mingari

http://www.w3.org/2001/XMLSchema#string

Marina Gualco

http://www.w3.org/2001/XMLSchema#string

Massimo Vitale

http://www.w3.org/2001/XMLSchema#string

Mirna Balsamo

http://www.w3.org/2001/XMLSchema#string

Nicola Solari

http://www.w3.org/2001/XMLSchema#string

P304

1407-1415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-11-2544

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22258454

http://www.w3.org/2001/XMLSchema#string